Cipla Ltd (CIPL.NS)
29 Jul 2016
MUMBAI Cipla Ltd, India's fifth-largest drugmaker by sales, reported a 69 percent fall in its quarterly profit, well below analysts' forecasts, due to one-off costs related to its business in Europe and some emerging markets.
* Says exiting some emerging markets, modifying Europe business
MUMBAI, May 24 Cipla Ltd, India's fifth-largest drugmaker by sales, reported a fall of 69 percent in its quarterly earnings on Tuesday, far short of analysts' forecasts.
** The pharmaceutical major will report Dec-qtr earnings later in the day